Ngā hua rapu - Reinhard Dummer
- E whakaatu ana i te 1 - 20 hua o te 267
- Haere ki te Whārangi Whai Ake
-
1
Human Leukocyte Antigen–G and Cancer Immunoediting mā Mirjana Urosevic, Reinhard Dummer
I whakaputaina 2008Revisão -
2
-
3
Immunological effects of BRAF+MEK inhibition mā Paolo A. Ascierto, Reinhard Dummer
I whakaputaina 2018Revisão -
4
-
5
A review of binimetinib for the treatment of mutant cutaneous melanoma mā Peter Koelblinger, Joëlle Dornbierer, Reinhard Dummer
I whakaputaina 2017Revisão -
6
Development of encorafenib for BRAF-mutated advanced melanoma mā Peter Koelblinger, Thuerigen Olaf, Reinhard Dummer
I whakaputaina 2017Revisão -
7
-
8
-
9
Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations mā Simone M. Goldinger, Carla Murer, P. Stieger, Reinhard Dummer
I whakaputaina 2013Revisão -
10
Hedgehog signaling in basal cell carcinoma mā Atsushi Otsuka, Mitchell P. Levesque, Reinhard Dummer, Kenji Kabashima
I whakaputaina 2015Revisão -
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. mā Jürgen C. Becker, Reinhard Dummer, A. Hartmann, Günter Burg, R. E. Schmidt
I whakaputaina 1991Artigo -
19
HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas mā Mirjana Urosevic, Joerg Willers, Beatrix Mueller, Werner Kempf, Guenter Burg, Reinhard Dummer
I whakaputaina 2002Artigo -
20
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Cancer research
Internal medicine
Melanoma
Biology
Cancer
Oncology
Immunology
Genetics
Immunotherapy
Gene
Pathology
Biochemistry
Cell biology
Metastatic melanoma
Immune system
Surgery
Adverse effect
Dermatology
Chemotherapy
MAPK/ERK pathway
Kinase
Gastroenterology
Lymphoma
Clinical trial
Randomized controlled trial
Vemurafenib
Chemistry
Ipilimumab
Signal transduction